Since the pandemic began, there have been 54.4 million cases of Covid-19 and 1.32 million deaths worldwide. The most affected countries are the United States (11.1 million cases), India (8.8) and Brazil (5.8). This week the newspaper ‘Daily Mail’ has published the space that the coronavirus occupies worldwide. And the data has not left anyone indifferent.
In other words, if we put together the coronavirus cells that have infected more than 54 million people, how much would they occupy? Barely 8 milliliters, an amount equivalent to a teaspoon and a half of coffee. A miniscule amount in terms of volume. How has something so small been able to disrupt everyone’s life in such a way? This is the question we now ask ourselves.
Aftermath of the coronavirus in healthy young people
Now that we know the space that the coronavirus occupies, it is worth paying attention to the conclusions they have reached UK researchers on the sequelae that Covid-19 leaves in healthy patients. This is a preliminary study in which scientists have found damage of varying degrees in different organs of the body in young people four months after being infected.
The study, baptized as ‘Converscan’, has as its main objective to carry out an evaluation of the long-term impact of coronavirus on organ health. To do this, scientists have analyzed 500 low-risk young people with symptoms of Covid-19. They have had blood tests, MRIs, physical measurements, and also a series of questionnaires.
Of the first 200 patients who participated in the study, 70% of them had deficiencies in one or more organs, mainly lungs, pancreas, liver and heart. In some of the cases, but not all, there was also a direct relationship between the symptoms and the damaged organs. Young people with lung and heart deficiencies had respiratory distress, while those with liver or pancreas damage suffered gastrointestinal symptoms.
This week the CEO of BioNtech spoke about the vaccine efficacy in an interview on the ‘BBC’. Ugur Sahin is very confident that the contagion and death curve will be reduced from now on by 50%.
In addition, he has explained that it will be necessary to receive a new dose of vaccine against coronavirus every year, every two years or every five years, depending on the antibody response of each individual.
Pfizer and BioNTech They estimate that during 2021 they will be able to produce about 1.3 billion vaccines, which would serve to immunize 650 million people globally, taking into account that each person needs two doses.
Therefore, it will be a “very difficult” winter, in the words of Ugur Sahin. It won’t be until mid 2021 when the impact of the coronavirus will be contained.